Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome

Overview of attention for article published in Frontiers in Pharmacology, February 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,875 followers.

New Research: Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome https://t.co/I49QTbxHzU #pharmacology

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.